Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection Clinical Trial

Official title:

Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03245632
• Other study ID #: SRRSH-CRKP
• Status: Not yet recruiting
• Phase: N/A
• First received: August 6, 2017
• Last updated: August 9, 2017
• Start date: August 2017
• Est. completion date: December 2019

Study information

• Verified date: August 2017
• Source: Sir Run Run Shaw Hospital
• Contact: Ying-zhi FANG, Master
• Phone: +86 57186006811
• Email: fyz4817[@]126.com
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Klebsiella pneumoniae is one of the most common pathogens causing nosocomial infection. Recently, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection. Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, and the rationality of the current therapy for the CRKP infection.

Description:

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, and the rationality of the current therapy for the CRKP infection

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 800
• Est. completion date: December 2019
• Est. primary completion date: July 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

• new confirmed noscomial infection of CRKP

Exclusion Criteria:

• Age<18, or >85 years old; Mixed infection of CRKP and other microbes

Related Conditions & MeSH terms

• Klebsiella Infections
• Klebsiella Pneumoniae Infection
• Pneumonia

Intervention

Other:
• Carbapenem-Resistant Klebsiella pneumoniae
no intervention, this is an obervational study.

Locations

Country	Name	City	State
China	Sir Run Run Shaw Hospital	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Sir Run Run Shaw Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CRKP infection	Culture postitive results confirmed the infection of CRKP	7 days